BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW)

CUSIP: G11217125

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / *W EXP 12/02/202
Total 13F shares
7,732,809
Share change
+7,732,809
Total reported value
$1,751,000
Price per share
$0.23
Number of holders
41
Value change
+$1,751,000
Number of buys
41

Quarterly Holders Quick Answers

What is CUSIP G11217125?
CUSIP G11217125 identifies BIOSW - BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) as of Q1 2022

As of 31 Mar 2022, BIOPLUS ACQUISITION CORP - *W EXP 12/02/202 (BIOSW) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,732,809 shares. The largest 10 holders included Saba Capital Management, L.P., HIGHBRIDGE CAPITAL MANAGEMENT LLC, Polar Asset Management Partners Inc., Linden Advisors LP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, MMCAP International Inc. SPC, AQR Arbitrage LLC, D. E. Shaw & Co., Inc., and Cubist Systematic Strategies, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.